Radiation-induced damage to normal tissue seriously disrupts the execution of radiotherapy (RT) and therefore attenuates its efficacy.
Exploring new strategies to enhance the efficacy and reduce toxicity of RT has great clinical importance.
Here, a PD-L1 affibody (Z
